{"trigger": ["Lymphocyte <extra_id_0> glucocorticoid receptor <extra_id_2> Protein <extra_id_1> : predictor of sertraline response in adolescent major depressive disorder ( MDD ) .", ""], "relation": []}
{"trigger": ["Major depressive disorder ( MDD ) in adolescents demonstrates resistance to tricyclic antidepressants and absence of hypercortisolemia .", ""], "relation": []}
{"trigger": ["The efficacy of serotonin reuptake inhibitors ( SRIs ) is uncertain , and response predictors are unavailable .", ""], "relation": []}
{"trigger": ["Abnormal fast feedback and negative feedback of the hypothalamic-pituitary-adrenal axis implicates a dampened limbic-hippocampal <extra_id_0> glucocorticoid type II receptor <extra_id_2> Protein <extra_id_1> ( <extra_id_0> GCII <extra_id_2> Protein <extra_id_1> ) .", ""], "relation": []}
{"trigger": ["We hypothesized that lymphocyte <extra_id_0> GCII <extra_id_2> Protein <extra_id_1> is altered in adolescent MDD and could serve as a marker for response to SRIs .", ""], "relation": []}
{"trigger": ["In an open-label study , adolescents ( n = 20 ) meeting DSM-III-R criteria for MDD showed baseline lymphocyte <extra_id_0> GCII <extra_id_2> Protein <extra_id_1> sites per cell ( sites / cell ) values of 793 +/- 106 versus 2 , 563 +/- 499 ( +/- SEM ) for matched controls ( n = 18 ) ( t = 3.5 ; df = 36 ; p < .001 ) .", ""], "relation": []}
{"trigger": ["<extra_id_0> GCII <extra_id_2> Protein <extra_id_1> was bimodally distributed , with SRI responders differing from nonresponders ( t = 3.9 ; df = 14 ; p < .001 ) .", ""], "relation": []}
{"trigger": ["<extra_id_0> GCII <extra_id_2> Protein <extra_id_1> accurately classified 90 percent of sertraline responders and 80 percent of nonresponders .", ""], "relation": []}
{"trigger": ["Only SRI responders showed <extra_id_0> GCII <extra_id_2> Protein <extra_id_1> sites / cell upregulated after 6 weeks of treatment ( t = 2.1 , df = 10 ; p < .05 ) .", ""], "relation": []}
